4basebio (LON:4BB) Stock Crosses Below 200 Day Moving Average – Here’s What Happened

4basebio PLC (LON:4BB) shares crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of GBX 523.96 and traded as low as GBX 509. 4basebio shares last traded at GBX 509, with a volume of 325 shares changing hands.

4basebio Stock Performance

The stock has a market cap of £78.82 million, a P/E ratio of -4.39 and a beta of 1.09. The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52. The firm’s 50-day moving average price is GBX 520.09 and its 200-day moving average price is GBX 523.96.

4basebio (LON:4BB) last released its earnings results on Monday, September 28th. The company reported GBX (0.57) EPS for the quarter. Sell-side analysts expect that 4basebio PLC will post -3.43 earnings per share for the current fiscal year.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.